Successful people are microdosing a powerful drug for glowing skin — and this founder is cashing in

Honeydew founders David Futoran (seated) and his longtime dermatologist, Dr. Joel Spitz. Honeydew For decades, Accutane has been a drug of last resort for persistent acne. A founder who designed a new platform to streamline regulatory red tape is changing access. People are microdosing Accutane and reporting fewer side effects. Dermatologists have mixed views. In the dermatology world, Accutane has a reputation as the nuclear option for bad acne . It's the only drug that can shrink oil glands, potentially clearing pimples for good. But it comes with serious risks — primarily: a high rate of birth defects if you take it and become pregnant. Other side effects include sun sensitivity, high cholesterol, mood changes, and joint pain. Parents are scared to put their teens on it. Dermatologists often reserve it for stubborn acne, after other creams, cleansers, antibiotics, and pills have been exhausted.